European Pharmaceutical Review

Learning the unwritten rules and dynamics of power
As part of EPR’s Women in Pharma series, Nawal Ouzren, CEO of Sensorion, talks to Science Editor Dr Zara Kassam about the diversity in drug development, creating a new growth mindset and elevating conversations beyond obvious beliefs...
The future of precision medicine
As part of EPR’s Women in Pharma series, Ruth March, VP and Head of Precision Medicine and Genomics at AstraZeneca, talks to Science Editor Dr Zara Kassam about decreasing the clinical risk associated with solid tumour biopsy, balancing a scientific career with family life and taking advantage of company initiatives…
Application Notes & Whitepapers 2018
Keeping up with the latest developments in pharma.
The data challenges of research & development and collaboration
In the biopharmaceuticals industry today, only 13 percent of therapeutics that enter Phase 1 of clinical trials go on to launch¹ – and the total journey from R&D to market can be anywhere between eight and 12 years.²

#soliloquy-container-60099{opacity:1}#soliloquy-container-60099 li>.soliloquy-caption{display:none}#soliloquy-container-60099 li:first-child>.soliloquy-caption{display:block} Learning the unwritten rules and dynamics of power

Learning the unwritten rules and dynamics of power

The data challenges of research & development and collaboration

Latest news

Application Note: Cost-effective approach to the purification of cannabinoids using CPC

Company Hub

HORIBA Scientific - the new global team created to better meet customers’ present and future needs

From our latest issue...

Product

True supply chain security is an eFingerprint away

Supplier news

Event

DIA Europe 2019

Webinar

Annex 1 Revisions: Let’s talk TOC and conductivity requirements for pharmaceutical water systems

Whitepaper

Application Note: Verification of three different Opadry whites using a handheld Raman analyser

Website development by e-Motive Media Limited.